146 related articles for article (PubMed ID: 1223998)
1. D & L amphetamine stereoisomers: comparative potencies in affecting the firing of central dopaminergic and noradrenergic neurons.
Bunney BS; Walters JR; Kuhar MJ; Roth RH; Aghajanian GK
Psychopharmacol Commun; 1975; 1(2):177-90. PubMed ID: 1223998
[TBL] [Abstract][Full Text] [Related]
2. Effects of catecholamine depleting drugs and d-amphetamine on self-stimulation of the substantia nigra and locus coeruleus.
Cooper BR; Konkol RJ; Breese GR
J Pharmacol Exp Ther; 1978 Mar; 204(3):592-605. PubMed ID: 24729
[TBL] [Abstract][Full Text] [Related]
3. Effects of crus cerebri lesions and repeated amphetamine treatment on the activity of nigral dopaminergic neurons.
Heidenreich BA; Rebec GV
Synapse; 2000 Oct; 38(1):80-6. PubMed ID: 10941143
[TBL] [Abstract][Full Text] [Related]
4. Comparison of effects of tetrahydropalmatine enantiomers on firing activity of dopamine neurons in substantia nigra pars compacta.
Sun BC; Huang KX; Jin GZ
Zhongguo Yao Li Xue Bao; 1992 Jul; 13(4):292-7. PubMed ID: 1360741
[TBL] [Abstract][Full Text] [Related]
5. Chloral hydrate anesthesia alters the responsiveness of identified midbrain dopamine neurons to dopamine agonist administration.
Kelland MD; Freeman AS; Chiodo LA
Synapse; 1989; 3(1):30-7. PubMed ID: 2919369
[TBL] [Abstract][Full Text] [Related]
6. D-Amphetamine-induced inhibition of central dopaminergic neurons: direct effect or mediated by a striatonigral feedback pathway?
Bunney BS; Aghajanian GK
Adv Biochem Psychopharmacol; 1977; 16():577-82. PubMed ID: 883560
[No Abstract] [Full Text] [Related]
7. Effects of clozapine on the activity of central dopaminergic and noradrenergic neurons.
Souto M; Monti JM; Altier H
Pharmacol Biochem Behav; 1979 Jan; 10(1):5-9. PubMed ID: 441095
[TBL] [Abstract][Full Text] [Related]
8. Neurophysiological investigation of effects of the D-1 agonist SKF 38393 on tonic activity of substantia nigra dopamine neurons.
Carlson JH; Bergstrom DA; Weick BG; Walters JR
Synapse; 1987; 1(5):411-6. PubMed ID: 2975067
[TBL] [Abstract][Full Text] [Related]
9. Excitation of noradrenergic cell firing by 5-hydroxytryptamine1A agonists correlates with dopamine antagonist properties.
Piercey MF; Smith MW; Lum-Ragan JT
J Pharmacol Exp Ther; 1994 Mar; 268(3):1297-303. PubMed ID: 8138943
[TBL] [Abstract][Full Text] [Related]
10. Endogenous DA-mediated feedback inhibition of DA neurons: involvement of both D(1)- and D(2)-like receptors.
Shi WX; Pun CL; Smith PL; Bunney BS
Synapse; 2000 Feb; 35(2):111-9. PubMed ID: 10611636
[TBL] [Abstract][Full Text] [Related]
11. Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease.
Srinivasan J; Schmidt WJ
Behav Brain Res; 2004 May; 151(1-2):191-9. PubMed ID: 15084435
[TBL] [Abstract][Full Text] [Related]
12. Electrophysiological and pharmacological characteristics of nigral dopaminergic neurons in the conscious, head-restrained rat.
Fà M; Mereu G; Ghiglieri V; Meloni A; Salis P; Gessa GL
Synapse; 2003 Apr; 48(1):1-9. PubMed ID: 12557266
[TBL] [Abstract][Full Text] [Related]
13. Effects of the serotonin 5-HT(7) receptor antagonist SB-269970 on the inhibition of dopamine neuronal firing induced by amphetamine.
Mnie-Filali O; Dahan L; Zimmer L; Haddjeri N
Eur J Pharmacol; 2007 Sep; 570(1-3):72-6. PubMed ID: 17586491
[TBL] [Abstract][Full Text] [Related]
14. Pallidal control of substantia nigra dopaminergic neuron firing pattern and its relation to extracellular neostriatal dopamine levels.
Lee CR; Abercrombie ED; Tepper JM
Neuroscience; 2004; 129(2):481-9. PubMed ID: 15501605
[TBL] [Abstract][Full Text] [Related]
15. Amphetamine elicited potential changes in vertebrate and invertebrate central neurons.
Tsai MC; Chen YH; Huang SS
Acta Biol Hung; 2000; 51(2-4):275-86. PubMed ID: 11034152
[TBL] [Abstract][Full Text] [Related]
16. Amphetamine normalizes the electrical activity of dopamine neurons in the ventral tegmental area following prenatal ethanol exposure.
Xu C; Shen RY
J Pharmacol Exp Ther; 2001 May; 297(2):746-52. PubMed ID: 11303066
[TBL] [Abstract][Full Text] [Related]
17. Phosphodiesterase 10A inhibition modulates the sensitivity of the mesolimbic dopaminergic system to D-amphetamine: involvement of the D1-regulated feedback control of midbrain dopamine neurons.
Sotty F; Montezinho LP; Steiniger-Brach B; Nielsen J
J Neurochem; 2009 May; 109(3):766-75. PubMed ID: 19236563
[TBL] [Abstract][Full Text] [Related]
18. Midbrain dopamine neurons: differential responses to amphetamine isomers.
Browder S; German DC; Shore PA
Brain Res; 1981 Mar; 207(2):333-42. PubMed ID: 7470912
[TBL] [Abstract][Full Text] [Related]
19. D1 receptor stimulation inhibits dopamine cell activity after reserpine treatment but not after chronic SCH 23390: an effect blocked by N-methyl-D-aspartate antagonists.
Huang KX; Walters JR
J Pharmacol Exp Ther; 1992 Jan; 260(1):409-16. PubMed ID: 1530977
[TBL] [Abstract][Full Text] [Related]
20. Effect of modafinil and amphetamine on the rat catecholaminergic neuron activity.
Akaoka H; Roussel B; Lin JS; Chouvet G; Jouvet M
Neurosci Lett; 1991 Feb; 123(1):20-2. PubMed ID: 1676498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
